FOCUS Investment Banking Represents Medvance Ltd. in Acquisition by NAMSA FOCUS closes another international deal in the healthcare industry

2024-02-12T23:33:53+00:00Healthcare, International News, International Transactions, Life Sciences, Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures, Newsletter|

Washington, DC (January 7, 2014) FOCUS, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced that its client, Medvance Ltd., has been acquired by NAMSA. FOCUS represented Medvance in the transaction, adding another international deal to its list of completed 2013 transactions.

Alzheimer’s Disease and the Growing Dementia Epidemic

2024-02-12T22:57:11+00:00Articles, Biotech, Healthcare, Newsletter, Technology Services|

Most of us know someone—relative, friend, or colleague—suffering from dementia, a medical term that describes symptoms of impaired cognition (memory and thinking), behavior, social abilities, and daily functioning. Dementia isn’t a specific disease and can range in severity from mild to severe. It has many different non-reversible and reversible causes.

2013: A Good Time to Sell Your Aerospace Supply Chain Company?

2024-01-22T10:57:37+00:00Articles, Government and Defense, Newsletter|

In real estate, it’s “location, location, location.” If you are the owner of an aerospace supply chain company, it may well be “timing, timing, timing.” In fact, 2013 may be one of the best times ever to sell your aerospace supply chain company—for a number of solid reasons, including many factors beyond any business owner’s control.

Go to Top